2 min read

EverHint – EMA 10/30 Crossover, SMA 20/50 Crossover – Top 13 Buy and Top 10 Sell Signals for Nov 12, 2026

23 signals (from 51 total). Healthcare leads (13). price range $10-$958. 1 with insider buying.

Excerpt: 23 signals (from 51 total). Healthcare leads (13). price range $10-$958. 1 with insider buying.

EMA 10/30 Crossover

Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.

Entry Criteria:

  • Buy: EMA10 crosses above EMA30
  • Sell: EMA10 crosses below EMA30
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh crossover: Detected on today's close

Holding period: 1-4 weeks | Risk level: Medium

🟢 Buy Signals (10 of 17)

Ranked by RSI (lower RSI for buy signals = more oversold)

# Ticker Company Sector Price Insider MCap
1 ADI Analog Devices, Inc. Technology $409.29 — $198.3B
2 BLTE Belite Bio, Inc Healthcare $169.96 — $6.8B
3 CEG Constellation Energy C... Utilities $282.40 — $100.1B
4 EPD Enterprise Products Pa... Energy $37.40 — $80.7B
5 FLR Fluor Corporation Industrials $49.52 — $6.3B
6 FUN Six Flags Entertainmen... Consumer Cyclical $11.19 — $1.1B
7 LSCC Lattice Semiconductor ... Technology $118.85 — $16.9B
8 MRCY Mercury Systems, Inc. Industrials $83.43 — $5.1B
9 NDSN Nordson Corporation Industrials $326.60 — $18.2B
10 PH Parker-Hannifin Corpor... Industrials $957.98 — $120.8B

🔴 Sell Signals (5 of 25)

# Ticker Company Sector Price Insider MCap
1 AMN AMN Healthcare Service... Healthcare $37.42 — $1.4B
2 ARQT Arcutis Biotherapeutic... Healthcare $27.53 — $3.5B
3 ASAN Asana, Inc. Technology $9.67 — $2.2B
4 BLBD Blue Bird Corporation Consumer Cyclical $55.45 — $1.7B
5 BZ Kanzhun Limited Communication Services $12.49 — $5.9B

SMA 20/50 Crossover

Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.

Entry Criteria:

  • Buy: SMA20 crosses above SMA50
  • Sell: SMA20 crosses below SMA50
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh crossover: Detected on today's close

Holding period: 2-6 weeks | Risk level: Medium

🟢 Buy Signals (3 of 3)

Ranked by RSI (lower RSI = more oversold for buy signals)

# Ticker Company Sector Price Insider MCap
1 MRK Merck & Co., Inc. Healthcare $146.95 — $362.3B
2 MTDR Matador Resources Company Energy $52.81 Buy +$618,468 $6.5B
3 ROIV Roivant Sciences Ltd. Healthcare $39.99 — $29.0B

🔴 Sell Signals (5 of 6)

# Ticker Company Sector Price Insider MCap
1 CVI CVR Energy, Inc. Energy $41.06 — $4.1B
2 DINO HF Sinclair Corporation Energy $102.15 — $17.5B
3 FIVN Five9, Inc. Technology $28.19 — $2.1B
4 ILMN Illumina, Inc. Healthcare $209.55 — $31.7B
5 PBR Petróleo Brasileiro S... Energy $18.10 — $116.6B

Insider buying (7d): MTDR (+$618,468)

Recent Headlines

ADI (Analog Devices, Inc.)

  • Lost Money on ADI Global Distribution Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 49.85% Share Price Drop
  • ADIG INVESTOR ALERT: Investigation of ADI Global Distribution Inc. Announced by Holzer & Holzer, LLC

BLBD (Blue Bird Corporation)

  • Blue Bird (BLBD) Registers a Bigger Fall Than the Market: Important Facts to Note

BLTE (Belite Bio, Inc)

  • What Belite Bio (BLTE) Said on Its Q3 Earnings Call
  • Belite Bio, Inc (BLTE) Q3 2026 Earnings Call Transcript

DINO (HF Sinclair Corporation)

  • Sinclair Advances DINOCARE® Fuel Platform With TOP TIERTM + Approved Gasoline

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

📢 If you found this useful, a quick like, share, or subscribe keeps EverHint moving forward.